These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15369650)

  • 21. First- and second-trimester screening for preeclampsia and intrauterine growth restriction.
    Tuuli MG; Odibo AO
    Clin Lab Med; 2010 Sep; 30(3):727-46. PubMed ID: 20638585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
    Khaliq A; Dunk C; Jiang J; Shams M; Li XF; Acevedo C; Weich H; Whittle M; Ahmed A
    Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors for intrauterine growth restriction.
    Albu AR; Anca AF; Horhoianu VV; Horhoianu IA
    J Med Life; 2014 Jun; 7(2):165-71. PubMed ID: 25408721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
    Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review: placental biomarkers for assessing fetal health.
    Manokhina I; Del Gobbo GF; Konwar C; Wilson SL; Robinson WP
    Hum Mol Genet; 2017 Oct; 26(R2):R237-R245. PubMed ID: 28595268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy.
    Steinborn A; Varkonyi T; Scharf A; Bahlmann F; Klee A; Sohn C
    Am J Reprod Immunol; 2007 Apr; 57(4):277-86. PubMed ID: 17362389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.
    Smith GC; Crossley JA; Aitken DA; Jenkins N; Lyall F; Cameron AD; Connor JM; Dobbie R
    Obstet Gynecol; 2007 Jun; 109(6):1316-24. PubMed ID: 17540803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction.
    Salomon O; Seligsohn U; Steinberg DM; Zalel Y; Lerner A; Rosenberg N; Pshithizki M; Oren M; Ravid B; Davidson J; Schiff E; Achiron R
    Am J Obstet Gynecol; 2004 Dec; 191(6):2002-9. PubMed ID: 15592283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction.
    Christians JK; Gruslin A
    Prenat Diagn; 2010 Sep; 30(9):815-20. PubMed ID: 20658698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
    Audibert F; Benchimol Y; Benattar C; Champagne C; Frydman R
    Fetal Diagn Ther; 2005; 20(1):48-53. PubMed ID: 15608460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia.
    Kaufmann P; Black S; Huppertz B
    Biol Reprod; 2003 Jul; 69(1):1-7. PubMed ID: 12620937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placental pathology in pregnancy complications.
    Huppertz B
    Thromb Res; 2011 Feb; 127 Suppl 3():S96-9. PubMed ID: 21262454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
    Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH
    Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short telomeres may play a role in placental dysfunction in preeclampsia and intrauterine growth restriction.
    Biron-Shental T; Sukenik-Halevy R; Sharon Y; Goldberg-Bittman L; Kidron D; Fejgin MD; Amiel A
    Am J Obstet Gynecol; 2010 Apr; 202(4):381.e1-7. PubMed ID: 20350645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First trimester markers for pre-eclampsia: placental vs. non-placental protein serum levels.
    Zwahlen M; Gerber S; Bersinger NA
    Gynecol Obstet Invest; 2007; 63(1):15-21. PubMed ID: 16864982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal-fetal interactions, predictive markers for preeclampsia, and programming.
    Huppertz B
    J Reprod Immunol; 2015 Apr; 108():26-32. PubMed ID: 25534924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placental development and function in women with a history of placenta-related complications: a systematic review.
    Reijnders IF; Mulders AGMGJ; Koster MPH
    Acta Obstet Gynecol Scand; 2018 Mar; 97(3):248-257. PubMed ID: 29125627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation.
    Pilalis A; Souka AP; Antsaklis P; Daskalakis G; Papantoniou N; Mesogitis S; Antsaklis A
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):135-40. PubMed ID: 17221926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PP13, maternal ABO blood groups and the risk assessment of pregnancy complications.
    Than NG; Romero R; Meiri H; Erez O; Xu Y; Tarquini F; Barna L; Szilagyi A; Ackerman R; Sammar M; Fule T; Karaszi K; Kovalszky I; Dong Z; Kim CJ; Zavodszky P; Papp Z; Gonen R
    PLoS One; 2011; 6(7):e21564. PubMed ID: 21799738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.